Sales and gross profit hit record highs, but operating profit declined due to higher investments. Sustainability led segment growth, while Life Science profits fell. FY2026 will see a temporary lull before new projects drive profit growth, aiming for SV2028 targets.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.